Kavar Capital Partners Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.7M Buy
5,587
+1,683
+43% +$1.72M 0.83% 37
2026
Q1
$3.59M Buy
3,904
+353
+10% +$358K 0.45% 55
2025
Q4
$3.82M Buy
3,551
+11
+0.3% +$10.5K 0.53% 48
2025
Q3
$2.7M Buy
3,540
+331
+10% +$246K 0.36% 63
2025
Q2
$2.5M Buy
3,209
+396
+14% +$308K 0.36% 67
2025
Q1
$2.32M Buy
2,813
+5
+0.2% +$4.16K 0.39% 64
2024
Q4
$2.17M Hold
2,808
0.37% 65
2024
Q3
$2.49M Sell
2,808
-35
-1% -$31.5K 0.39% 64
2024
Q2
$2.57M Buy
2,843
+25
+0.9% +$20K 0.46% 60
2024
Q1
$2.19M Buy
2,818
+1,920
+214% +$1.37M 0.4% 64
2023
Q4
$523K Sell
898
-53
-6% -$30.9K 0.06% 130
2023
Q3
$511K Hold
951
0.11% 106
2023
Q2
$446K Buy
951
+231
+32% +$96.9K 0.1% 105
2023
Q1
$247K Hold
720
0.05% 136
2022
Q4
$263K Buy
720
+60
+9% +$21.3K 0.06% 123
2022
Q3
$213K Hold
660
0.05% 132
2022
Q2
$214K Buy
+660
New +$198K 0.05% 153
2019
Q3
Sell
-500
Closed -$55K 317
2019
Q2
$55K Buy
+500
New +$58.9K 0.02% 220
2018
Q3
Sell
-100
Closed -$9K 266
2018
Q2
$9K Hold
100
﹤0.01% 325
2018
Q1
$8K Buy
+100
New +$8.05K ﹤0.01% 337
2016
Q1
Sell
-100
Closed -$8K 252
2015
Q4
$8K Hold
100
0.01% 279
2015
Q3
$8K Sell
100
-100
-50% -$8.44K 0.01% 290
2015
Q2
$16K Buy
+200
New +$15.2K 0.01% 264

Other funds holding LLY

Kavar Capital Partners Group's LLY Position: Q2 2026 in Review

Kavar Capital Partners Group increased its Eli Lilly (LLY) stake by 43% in Q2 2026, buying an estimated $1.72M and bringing the position to 5,587 shares worth $6.7M. The position accounts for 0.83% of the portfolio, ranked #37.

Kavar Capital Partners Group first reported a position in LLY in Q2 2015 and has held it in 23 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kavar Capital Partners Group held 5,587 shares of Eli Lilly worth $6.7M as of Q2 2026.
  • Kavar Capital Partners Group bought 1,683 Eli Lilly shares in Q2 2026, an estimated $1.72M.
  • Eli Lilly made up 0.83% of Kavar Capital Partners Group's portfolio in Q2 2026, its #37 holding.
  • Kavar Capital Partners Group first reported a position in Eli Lilly in Q2 2015 and has held it in 23 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.